TOPS SURGICAL SPECIALTY HOSPITAL — History
CCN 450774 | 3-year financial timeline | COVID resilience: 77/100
🛡️ Public data only — no PHI permitted on this instance.
$61M
Latest Revenue (FY2022)
+22.6%
Revenue CAGR (3yr)
30.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $40M | $48M | $61M | +27.4% | +22.6% |
| Operating Expenses | $31M | $34M | $42M | +22.6% | +17.3% |
| Operating Margin | 24.1% | 27.7% | 30.4% | +9.8% | +12.4% |
| Net Income | $10M | $13M | $18M | +39.9% | +37.8% |
| Licensed Beds | 15 | 15 | 15 | +0.0% | +0.0% |
| Total Patient Days | 984 | 1,028 | 1,154 | +12.3% | +8.3% |
| Medicare Day % | 24% | 22% | 26% | +19.6% | +4.7% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 77/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +50.2% ($40M → $61M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+22.6%
This Hospital
+7.6%
State Avg
Latest Margin
30.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $71M | 33.6% |
| FY2024 (proj) | $81M | 36.8% |
| FY2025 (proj) | $91M | 40.0% |